OliPass Corp
KOSDAQ:244460
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
OliPass Corp
KOSDAQ:244460
|
KR |
|
Refex Industries Ltd
NSE:REFEX
|
IN |
|
J
|
Johor Plantations Group Bhd
KLSE:JPG
|
MY |
OliPass Corp
OliPass Corp. develops biological products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2019-09-20. The firm principally manufactures and sells nonopioid analgesic, hyperlipidemia medicine, ocular angiogenesis inhibitor, duchenne dystrophy medicine, cancer immunotherapy medicine and other products. In addition, the Company researches, develops and sells functional cosmetics through the artificial gene platform technology.
OliPass Corp. develops biological products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2019-09-20. The firm principally manufactures and sells nonopioid analgesic, hyperlipidemia medicine, ocular angiogenesis inhibitor, duchenne dystrophy medicine, cancer immunotherapy medicine and other products. In addition, the Company researches, develops and sells functional cosmetics through the artificial gene platform technology.